Center for Scientific Review; Notice of Closed Meeting, 787 [2019-00330]
Download as PDF
<![CDATA[
787
Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices
Dated: January 25, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00323 Filed 1–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cell Biology
Integrated Review Group; Molecular and
Integrative Signal Transduction Study
Section.
Date: February 7–8, 2019.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Torrance Marriott Redondo Beach,
3635 Fashion Way, Torrance, Torrance, CA
90503.
Contact Person: Charles Selden, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187,
MSC 7840, Bethesda, MD 20892, 301–451–
3388, seldens@mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 25, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00330 Filed 1–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Treatment Episode Data Set
(TEDS) (OMB No. 0930–0335)—
Extension
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is requesting an extension to
Number of
respondents
(states/
jurisdictions)
amozie on DSK3GDR082PROD with NOTICES1
Type of activity
Responses per
respondent
collect the Treatment Episode Data Set
(TEDS) data collection (OMB No. 0930–
0335), which expires on March 31,
2019. TEDS is a compilation of clientlevel substance use treatment admission
and discharge data submitted by states
on clients treated in facilities that
receive state funds. SAMHSA is also
requesting an extension to collect the
client-level mental health admission
and update/discharge data (MH–TEDS/
MH–CLD) submitted by states on clients
treated in facilities that receive state
funds (also OMB No. 0930–0335).
TEDS/MH–TEDS/MH–CLD data are
collected to obtain information on the
number of admissions and updates/
discharges at publicly funded substance
use treatment and mental health
services facilities and on the
characteristics of clients receiving
services at those facilities.
TEDS/MH–TEDS/MH–CLD also
monitor trends in the demographic,
substance use, and mental health
characteristics of admissions. In
addition, several of the data elements
used to calculate performance measures
for the Substance Abuse Block Grant
(SABG) and Mental Health Block Grant
(MHBG) applications are collected
through the TEDS/MH–TEDS/MH–CLD.
Most states collect the TEDS/MH–
TEDS/MH–CLD data elements from
their treatment providers for their own
administrative purposes and are able to
submit a cross-walked extract of their
data to TEDS/MH–TEDS/MH–CLD. No
changes are expected in the TEDS/MH–
TEDS/MH–CLD data elements that are
collected.
Estimated annual burden for the
separate TEDS/MH–TEDS/MH–CLD
activities is as follows:
Total
responses
Hours
per response
Total burden
hours
TEDS Admission Data .......................................................
TEDS Discharge Data .......................................................
TEDS Crosswalks ..............................................................
MH–CLD BCI Data ............................................................
MH–CLD SHR Data ...........................................................
MH–TEDS Admissions Data ..............................................
MH–TEDS Update/Discharge Data ...................................
MH–TEDS Crosswalks ......................................................
52
52
5
30
30
29
29
10
4
4
1
1
1
4
4
1
208
208
5
30
30
116
116
10
6.25
8.25
10
30
5
6.25
8.25
10
1,300
1,716
50
900
150
725
957
100
Total ............................................................................
59
..........................
723
........................
5,898
Written comments and
recommendations concerning the
proposed information collection should
be sent by March 4, 2019 to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
VerDate Sep<11>2014
20:21 Jan 30, 2019
Jkt 247001
Office of Management and Budget
(OMB). To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
sent through the U.S. Postal Service,
commenters are encouraged to submit
PO 00000
Frm 00142
Fmt 4703
Sfmt 4703
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–7285.
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Page 787]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Cell Biology Integrated Review Group;
Molecular and Integrative Signal Transduction Study Section.
Date: February 7-8, 2019.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Torrance Marriott Redondo Beach, 3635 Fashion Way,
Torrance, Torrance, CA 90503.
Contact Person: Charles Selden, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187, MSC 7840, Bethesda, MD
20892, 301-451-3388, seldens@mail.nih.gov.
This meeting notice is being published less than 15 days in
advance of the meeting due to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 25, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00330 Filed 1-30-19; 8:45 am]
BILLING CODE 4140-01-P
